Aether Industries Ltd. · NSE:AETHER
Aether Industries — Q2/H1 FY2025 Earnings Presentation
28 slides from Aether Industries's earnings presentation, Oct 18, 2024
Slide 1: Exchange filing letter: Presentation on Financial Results
October 18, 2024 Ref. No.: AIL/SE/50/2024-25 To, BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Dalal Street, Fort, Bandra Kurla Complex, Bandra (E), Mumbai-400001, MH. Mumbai-400051, MH. Scrip Code: 543534 Symbol: AETHER Dear Madam / Sir, Subject: Pr
Slide 2: Q2/H1 2024-25
Q2/H1 2024-25
Slide 3: Agenda
Agenda Innovation for a Sustainable Future 01 Aether’s Focus (03) 02 Aether Today (04) 03 Aether’s Business Segments (05) 04 Highlights (06) 05 Financial Snapshots (07) 06 Announcements (13) 07 Expansions (14) 08 QEHS (17) 09 Business Segments (18) 10 Research & Development (19) 11 QIP Funds Utilisa
Slide 4: Aether's Focus
Aether’s Focus Renewables Agrochemicals & Sustainability • Saudi Aramco Technologies Company - CO2nverge® Polyols: up to 40% by weight carbon dioxide Introducing • Electrolyte additives for lithium ion batteries - Global Lithium-Ion Battery Producer. New Business • Novoloop, Inc. - Polymer depolymer
Slide 5: Aether Today
Aether Today 6,511 5,970 5,957 4,538 EBITDA % Revenue 4,011 30.4 29.3 29.1 3,038 25.3 25.3 2,033 24.4 24.3 1,092 21.7 FY18 FY19 FY20 FY21 FY22 FY23 FY24 H1 FY25 FY18 FY19 FY20 FY21 FY22 FY23 FY24 H1 FY25 PAT % 19.5 Export# 18.2 46.6% 17.0 Others LSM 15.7 1.7% 61.2% 13.2 13.8 CRAMS 11.5 14.2% By Busi
Slide 6: Business Segments
Business Segments Imaging 1% Pharma Pharma Multiple 47% Multiple 52% 2% 4% Photography Photography 3% 4% Textiles Textiles By Segment 3% By Segment 2% Q1 FY25 Q2 FY25 Coatings Coatings 4% 4% Material Science Material Science 6% 7% Agro Agro 26% 33% Standalone
Slide 7: Highlights
CEM - Seqens Group take- 5MW Solar Power 5MW Auto Site 2 75% of the site operational or-pay contract, Aether will produce a series Tracker Solar Plant commissioned in June 24, with all regulatory approvals in place and of natural bio-based products exclusively. balance 10MW to be commissioned in Q3F
Slide 8: Q-o-Q Standalone
Q-o-Q Standalone Revenue EBITDA PAT 2,091 642 381 31% 18% Q2 FY25 9% 22% 26% 1,920 524 303 27% 16% Q1 FY25 Q-o-Q is Comparison of Q2 FY25 with Q1 FY25 All numbers are in INR MM
Slide 9: Y-o-Y Standalone
Y- -Y Standalone Revenue EBITDA PAT 2,091 642 381 31% 18% Q2 FY25 17% 5% 1% 1,793 612 378 34% 21% Q2 FY24 Y-o-Y is comparison of Q2 FY25 with Q2 FY24 All numbers are in INR MM
Slide 10: H1 FY-o-H1 FY Standalone
H1FY-o-H1FY Standalone Revenue EBITDA PAT 4,011 1,166 683 29% 17% H1 FY25 17% 7% 1% 3,431 1,085 680 32% 20% H1 FY24 H1FY-o-H1FY is comparison of H1 FY25 with H1 FY24 All numbers are in INR MM
Slide 11: Q-o-Q Consolidated
Q-o-Q Consolidated Revenue EBITDA PAT 2,098 613 348 29% 17% Q2 FY25 9% 18% 16% 1,920 521 299 27% 16% Q1 FY25 Q-o-Q is Comparison of Q2 FY25 with Q1 FY25 All numbers are in INR MM
Slide 12: Y-o-Y Consolidated
Y-o-Y Consolidated Revenue EBITDA PAT 2,098 613 348 29% 17% Q2 FY25 18% 2% 5% 1,783 601 367 34% 21% Q2 FY24 Y-o-Y is comparison of Q2 FY25 with Q2 FY24 All numbers are in INR MM
Slide 13: H1 FY-o-H1 FY Consolidated
H1FY-o-H1FY Consolidated Revenue EBITDA PAT 4,017 1,134 647 28% 16% H1 FY25 18% 6% 3% 3,417 1,071 665 31% 19% H1 FY24 H1FY-o-H1FY is comparison of H1 FY25 with H1 FY24 All numbers are in INR MM
Slide 14: Contract Manufacturing Agreement with SEQENS Group
Announcement Contract Manufacturing Agreement with SEQENS Group Aether has entered into a Contract / Exclusive Manufacturing Agreement with Chemoxy International Limited, a wholly-owned subsidiary of the SEQENS group (Seqens). Under this take-or-pay contract, Aether will produce a series of natural
Slide 15: Site 3++
Site 3++ • Site expansion - construction on schedule! • Equipment and machinery secured • All approvals secured - ready for a smooth transition • Commissioning expected by end of FY25
Slide 16: Site 4
Site 4 • Site ready and commissioned in March 2024 • SSA with Baker Hughes executed • Commercial orders to start soon • 6 Products to be launched currently - in phased manner
Slide 17: Site 5
Site 5 • EC approved in December 2023, ordering of equipment started • Ground digging, wall fencing and plinth work completed • Building work started for phase one production block • Phase one expected to be commissioned by end of FY26
Slide 18: QEHS
QEHS ISO 9001 Indian GMP 17%* ISO 45001 UN Global 7.06% - QC/QA/ADL Team. 4.50% - Safety Team ISO 14001 Ecovadis Medal 5.12% - Environment Team ISO 27001 20* times our facilities have been audited by Aether has implemented QEHS system to achieve a holistic approach to excellence. This includes Impro
Slide 19: Business Models
Business Models 57% 14% 27% Large Scale Contract Research & Contract | Exclusive Manufacturing Manufacturing Services Manufacturing Advanced intermediates and Contract research, scale-up services, Manufacture under contractual speciality chemicals with application technology development, low volume
Slide 20: R&D expenses 308.50 MM or 7.69% of total revenue
Differentiating Factor ₹ 987 (15.4%) R&D expenses 308.50 MM or 7.69% of total revenue in H1 FY25 ₹ 501 (7.5%) ₹ 393 (6.6%) ₹ 193 (4.3%) ₹ 121 (4%) ₹ 53 (2.6%) All numbers are in INR MM - Standalone FY19 FY20 FY21 FY22 FY23 FY24
Slide 21: QIP Fund Utilisation
QIP Fund Utilisation Objects of Issue Amount as per Amount % Amount Pending to be PPD (A) Utilised (B) Utilised (C) Utilised (D = A - B) Funding capex for Green eld Project - Site 3++ 1,830.00 708.61 38.72% 1,121.39 Funding capex for Green eld Project - Site 5 (1st phase) 3,300.00 459.73 13.93% 2,84
Slide 22: Standalone Statement of Assets and Liabilities
Standalone Statement of Assets and Liabilities ASSETS H1 FY25 FY24 EQUITY AND LIABILITIES H1 FY25 FY24 Unaudited Audited Unaudited Audited Non-current assets Equity Property, plant and equipment Equity share capital 6,199 6,097 1,326 1,326 Capital work-in-progress Other equity 3,220 2,143 20,063 19,
Slide 23: Standalone Financial Results
Standalone Financial Results Particulars Q2FY25 Q1FY25 Q2FY24 H1 FY25 H1 FY24 FY24 Unaudited Unaudited Unaudited Unaudited Unaudited Audited Revenue from operations 1,964 1,800 1,642 3,764 3,253 5,957 Other income 127 120 152 247 178 443 Total income 2,091 1,920 1,794 4,011 3,431 6,400 Cost of goods
Slide 24: Standalone Statement of Cash Flows
Standalone Statement of Cash Flows Particulars H1 FY25 FY24 Unaudited Audited Cash generated from operations 959 153 Net cash from operating activities 789 (20) Net cash (used in) investing activities (1,389) (3,989) Net cash used in nancing activities 124 8,542 Net increase / (decrease) in cash and
Slide 25: Consolidated Statement of Assets and Liabilities
Consolidated Statement of Assets and Liabilities ASSETS H1 FY25 FY24 EQUITY AND LIABILITIES H1 FY25 FY24 Unaudited Audited Unaudited Audited Non-current assets Equity Property, plant and equipment Equity share capital 7,035 6,933 1,326 1,326 Capital work-in-progress Other equity 3,401 2,261 19,971 1
Slide 26: Consolidated Financial Results
Consolidated Financial Results Particulars Q2FY25 Q1FY25 Q2FY24 H1 FY25 H1 FY24 FY24 Unaudited Unaudited Unaudited Unaudited Unaudited Audited Revenue from operations 1,988 1,800 1,642 3,788 3,253 5,982 Other income 110 120 141 229 164 392 Total income 2,098 1,920 1,783 4,018 3,417 6,374 Cost of goo
Slide 27: Consolidated Statement of Cash Flows
Consolidated Statement of Cash Flows Particulars H1 FY25 FY24 Unaudited Audited Cash generated from operations 689 8 Net cash from operating activities 519 (165) Net cash (used in) investing activities (1,318) (4,239) Net cash used in nancing activities 323 8,938 Net increase / (decrease) in cash an
Slide 28: Forward-looking statements disclaimer
Certain statements and opinions with respect to the anticipated future performance of the company in the presentation (“forward - looking statements”), which re ect various assumptions concerning the strategies, objectives and anticipated results may or may not prove to be correct. Such forward -loo
Aether Industries — Q2/H1 FY2025 Earnings Presentation on 6ix